Jaattela A, Pyorala K
Br J Clin Pharmacol. 2012; 3(4):655-60.
PMID: 22216509
PMC: 1428917.
DOI: 10.1111/j.1365-2125.1976.tb04890.x.
Man in t Veld A, Wenting G, Boomsma F, Verhoeven R, SCHALEKAMP M
Br J Clin Pharmacol. 1980; 9(6):547-51.
PMID: 7387812
PMC: 1429995.
DOI: 10.1111/j.1365-2125.1980.tb01079.x.
EDMONSTONE W, Manghani K, Bell A, McLeod M, Burland W
Br J Clin Pharmacol. 1981; 12(4):567-72.
PMID: 7295490
PMC: 1401881.
DOI: 10.1111/j.1365-2125.1981.tb01266.x.
Robinson B, Collier J, Dobbs R
Br J Clin Pharmacol. 1980; 9(4):407-12.
PMID: 6769454
PMC: 1429974.
DOI: 10.1111/j.1365-2125.1980.tb01069.x.
Majid P, Meeran M, Benaim M, Sharma B, Taylor S
Br Heart J. 1974; 36(6):588-96.
PMID: 4850484
PMC: 458864.
DOI: 10.1136/hrt.36.6.588.
Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.
Vedin J, Wilhelmsson C, WERKO L
Br Heart J. 1973; 35(12):1285-92.
PMID: 4586374
PMC: 458796.
DOI: 10.1136/hrt.35.12.1285.
Beta-adrenergic receptor blocking drugs in hypertension.
Simpson F
Drugs. 1974; 7(1):85-105.
PMID: 4152167
DOI: 10.2165/00003495-197407010-00006.
Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
Aenishanslin W, Dubach U, Imhof P, Turri M
Eur J Clin Pharmacol. 1972; 4(3):177-81.
PMID: 4144064
DOI: 10.1007/BF00561142.
Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
Brecht H, Banthien F, SCHOEPPE W
Klin Wochenschr. 1976; 54(22):1095-105.
PMID: 1003867
DOI: 10.1007/BF01469113.
Clinical pharmacokinetics of hydrallazine.
Talseth T
Clin Pharmacokinet. 1977; 2(5):317-29.
PMID: 913002
DOI: 10.2165/00003088-197702050-00001.
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Persson I
Eur J Clin Pharmacol. 1975; 9(2-3):91-3.
PMID: 786690
DOI: 10.1007/BF00614002.
Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.
Motolese M, MUIESAN G, Colombi A
Eur J Clin Pharmacol. 1975; 8(1):21-31.
PMID: 786673
DOI: 10.1007/BF00616411.
Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.
Davies I, Sever P, Rosenthal T
Br J Clin Pharmacol. 1979; 8(1):49-51.
PMID: 399592
PMC: 1429708.
DOI: 10.1111/j.1365-2125.1979.tb05908.x.
The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
Prichard B
Br J Clin Pharmacol. 1978; 5(5):379-99.
PMID: 26370
PMC: 1429347.
DOI: 10.1111/j.1365-2125.1978.tb01644.x.
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Wollam G, GIFFORD Jr R, TARAZI R
Drugs. 1977; 14(6):420-60.
PMID: 23284
DOI: 10.2165/00003495-197714060-00002.
Uses of beta-adrenoceptor blocking drugs.
Prichard B, McDevitt D, Shanks R
J R Coll Physicians Lond. 1976; 11(1):35-57.
PMID: 10438
PMC: 5368760.
